Genticel
Develops innovative immunotherapies
Genticel has raised €31M across 2 funding rounds from 4 investors, most recently a Series D+ round in Apr 2013. Based in Argueil, France; founded 2001; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€31M
€31,331,538
Funding rounds
2
Investors
4
distinct backers
Active since
2010-04
latest 2013-04
Funding by year
EUR raised per yearGenticel — funding by year — interactive chart.
Data table
| Genticel — funding by year | |
|---|---|
| 2010 | €13M |
| 2013 | €18M |
Signals
High confidenceRaise-next likelihood12
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood4
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (25y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-04-01 | Series D+ | €18M | Amundi Private Equity Funds,Edmond de Rothschild Venture Capital,IDInvest Partners,Wellington Partners | View deal → |
| 2010-04-01 | Series C | €13M | Amundi Private Equity Funds,Edmond de Rothschild Venture Capital,IDInvest Partners | View deal → |
Investors
4Similar companies
same sector, similar size- uTest_Vamsi€60MFrance · Healthtech
- Therachon€31MFrance · Healthtech
- Echosens€31MFrance · Healthtech
- THERAVECTYS€24MFrance · Healthtech
- Biom'Up€38MFrance · Healthtech
- Genfit€34MFrance · Healthtech
Global coverage: FundingData